GlassScriptPhysician profile
Kaylyn Munroe
NPI 1932812765
$2,371.95
in general payments reported to CMS, 2019-2025
11 companies · $873 in 2025
The $873 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $476 · 2024: $1,022 · 2025: $873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,371.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,146.47 | 2023-2025 | Breztri, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $455.17 | 2023-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Harmony Biosciences LLC | $228.52 | 2023-2025 | Wakix |
| Genzyme Corporation | $208.17 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $164.03 | 2023-2025 | Dupixent |
| Amgen INC. | $42.33 | 2024-2025 | Tezspire |
| Mylan Specialty L.P. | $35.17 | 2023-2024 | Yupelri |
| Insmed, INC. | $30.82 | 2024-2025 | Arikayce |
| Novartis Pharmaceuticals Corporation | $27.25 | 2023 | |
| Baxter Healthcare | $20.63 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Idorsia Pharmaceuticals US INC | $13.39 | 2024 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaylyn Munroe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.